Comstock Inc. 2023 Q1 SEC Filing Summary
Business Context and Reporting Period
Comstock Inc. filed its unaudited Form 10-Q for the three months ended March 31, 2023, with comparison to the three months ended March 31, 2022. The company develops technologies involving renewable fuels, battery-metal recycling, artificial intelligence-enabled materials discovery, mining and strategic investments. The company reported three operating segments: renewable energy, mining, and strategic and other investments.
Operations remain primarily focused on technology development and commercialization rather than established product sales. Management stated that first-quarter results may not be indicative of full-year 2023 performance.
Key Financial Metrics
| Metric | Q1 2023 | Q1 2022 | Change |
|---|---|---|---|
| Revenue | $30,750 | $54,625 | Down $23,875 |
| Operating expenses | $5.11 million | $4.44 million | Up $665,486 |
| Loss from operations | $5.08 million | $4.39 million | Loss increased $689,361 |
| Net loss | $5.68 million | $6.55 million | Improved $865,281 |
| Net loss attributable to Comstock | $5.67 million | $6.38 million | Improved $709,618 |
| Basic and diluted loss per share | $0.06 | $0.09 | Improved |
| Cash flow from operations | $(3.85) million | $(3.86) million | Nearly unchanged |
| Cash flow from investing | $7.87 million | $(0.23) million | Improved $8.09 million |
| Cash flow from financing | $1.57 million | $0.42 million | Up $1.14 million |
Revenue consisted of operating lease revenue and declined primarily because of lower lease revenue from land and buildings. No revenue was reported by the renewable energy segment; mining generated $22,950 and strategic and other investments generated $7,800.
Gross margin was not presented because the filing reports no cost of sales or gross profit line. Operating expenses included selling, general and administrative expense of $3.39 million, research and development expense of $1.27 million, depreciation and amortization of $631,041, and a $178,193 gain on sale of property.
At March 31, 2023, cash, cash equivalents and restricted cash were $8.11 million, compared with $2.52 million at December 31, 2022. Current assets were $35.51 million and current liabilities were $40.94 million, producing a working-capital deficit of $5.43 million. Total assets were $104.99 million and total stockholders’ equity was $54.32 million.
Total debt was $8.34 million before discounts and $7.07 million net of discounts and issuance costs, compared with $7.92 million net at December 31, 2022. Current debt was $3.43 million and long-term debt was $3.64 million. Significant obligations included the $2.00 million Alvin Fund note due October 2023, the $4.29 million GHF note due December 2024, and the remaining Ionic convertible note balance.
Material Changes Versus the Prior Comparable Period
- Net loss improved primarily because Q1 2022 included $4.48 million of impairment losses involving intangible assets, MCU-related investments and notes receivable. No impairment losses were recorded in Q1 2023.
- Operating performance weakened: revenue declined 44%, operating expenses increased 15%, and operating loss increased 16%.
- SG&A increased $984,206, principally due to higher employee costs, executive incentive compensation, payroll administration and mining-related costs.
- Research and development expense increased $72,961, while depreciation and amortization declined $213,488, partly because amortization ceased on assets classified as held for sale.
- Derivative fair-value gains fell to $698,595 from $3.07 million in Q1 2022. Q1 2023 included gains related to Ionic, LINICO, GenMat and Haywood instruments.
- Interest expense increased $290,454 to $615,178 because of debt and original issue discount amortization associated with borrowings initiated in late 2022.
- Common shares outstanding increased substantially through equity issuance and debt conversion. Shares issued and outstanding at March 31, 2023 were 103.04 million, compared with 91.44 million at December 31, 2022. After quarter-end, Ionic returned excess shares, and outstanding shares were 102.71 million as of May 3, 2023.
- Investing cash flow benefited from $11.0 million of proceeds related to the AQMS lease and related assets, partially offset by $550,000 of additional advances to Sierra Springs Opportunity Fund and $788,059 of purchases of mineral rights, water rights and property, plant and equipment.
Guidance, Outlook, Risks and Unusual Items
Management identified commercialization as its primary 2023 objective. Planned priorities include executing one or more cellulosic-fuels license agreements, securing revenue-generating supply commitments for metals recycling, advancing GenMat’s generative artificial intelligence technology toward commercial readiness, and progressing mining resource evaluations.
- Cellulosic fuels were reported at technology readiness level 6 at December 2022, with a 2023 goal of level 7 and one or more early-adopter licensing agreements. Management stated that commercial licenses could produce upfront engineering fees and recurring royalties over 15 to 20 years, but no such revenue is reported in Q1 2023.
- Metals recycling was at technology readiness level 5 at December 2022, with a 2023 goal of level 6. Specific second-quarter objectives were to be provided later.
- GenMat, in which Comstock holds a 48.19% investment interest, was at technology readiness level 4 at December 2022, with a 2023 goal of level 6 and potential commercialization with early-adopter customers.
- Management expects to monetize up to $30 million of non-strategic assets during 2023.
- The AQMS facility transaction was not complete at March 31, 2023. Subsequent to quarter-end, Comstock paid $12.0 million to acquire the facility and placed $1.5 million in escrow for environmental liabilities. Management expects to net more than $14.0 million in cash and estimates a total gain of approximately $4.9 million; approximately $0.2 million was recognized in Q1.
- The company reported recurring operating losses, an accumulated deficit of $297.2 million, and a working-capital deficit. Management believes existing cash, asset sales, investments, licensing and technology-related inflows will fund operations and commitments for the next 12 months, but stated that failure to obtain required funds could raise substantial doubt about continuation as a going concern.
- Liquidity risks include higher-than-expected operating, research, exploration and investment spending; delays or lower proceeds from asset sales; inability to raise equity or other financing; declines in property values or share price; and non-repayment of $5.54 million of non-interest-bearing advances to SSOF.
- The company remains exposed to speculative technology commercialization, mineral exploration, permitting, environmental regulation, commodity prices, equipment and operational risks, litigation, dilution, derivative liabilities and the ability to satisfy debt and lease obligations.
- Executive bonuses of $970,000 for named executive officers other than the CEO were approved on April 28, 2023, payable in the second and third quarters of 2023.
Important Facts for Investors to Verify
- Whether the AQMS facility sale and related asset transaction closes as expected and produces the stated net cash proceeds and estimated gain.
- Whether Comstock secures binding licensing agreements for its cellulosic-fuels technology and revenue-generating supply commitments for metals recycling.
- The timing and economics of the planned sale of up to $30 million of non-strategic assets.
- Cash burn, working-capital needs and the company’s ability to fund operations without substantial additional equity issuance or other financing.
- Upcoming debt maturities, including the $2.0 million Alvin Fund note due October 2023, and the terms and dilution effects of convertible debt and equity facilities.
- The collectability and repayment timing of the $5.54 million SSOF advances and the company’s related-party exposure.
- Changes in derivative liabilities, asset-sale obligations, environmental liabilities and other contingent commitments.
- Whether GenMat, renewable-fuels, metals-recycling and mining initiatives achieve the stated technology-readiness and commercialization milestones.